Search - tctmd.com

Displaying 101 - 120 of 541

Sort: Relevancy | Date

News Daily News

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

Todd Neale

October 09, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2020

Shelley Wood

October 01, 2020

News Daily News

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

Michael O'Riordan

September 18, 2020

News Conference News ESC 2020

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

Yael L. Maxwell

September 08, 2020

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

News Daily News

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Michael O'Riordan

August 11, 2020

News Daily News

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

L.A. McKeown

August 10, 2020

News Daily News

Reduced-Dose Prasugrel Works Well in Older, Low-Weight ACS Patients

Todd Neale

July 21, 2020

News Daily News

THALES: Ticagrelor Plus Aspirin Cuts Repeat Events After Stroke, TIA

Todd Neale

July 16, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2020

Shelley Wood

July 02, 2020

Podcast TCTMD Talking Points

TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

July 01, 2020

News Conference News EuroPCR 2020

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Michael O'Riordan

June 30, 2020

News Daily News

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

Yael L. Maxwell

June 30, 2020

News Daily News

TICONC: Ticagrelor May Cut Tumor-Induced Platelet Aggregation in Cancer Patients

L.A. McKeown

June 17, 2020

News Daily News

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Michael O'Riordan

June 08, 2020

News Daily News

Stent Thrombosis May Be Presenting Feature of COVID-19

Yael L. Maxwell

June 08, 2020

News Daily News

Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI

Yael L. Maxwell

June 03, 2020

News Daily News

FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention

Shelley Wood

June 01, 2020

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

Presentation

Clopidogrel vs Ticagrelor or Prasugrel in Patients 70 Years or Older With NTSE ACS: POPular Age

April 27, 2020

Advertisement

Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5

TCTMD’s Top 10 Most Popular Stories for September 2020

‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests

More Bleeding, Death With Ticagrelor Over Clopidogrel in Elderly Post-MI Patients: SWEDEHEART

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention

Analysis Supports Short DAPT Followed by P2Y12 Inhibitor Monotherapy After DES PCI

Reduced-Dose Prasugrel Works Well in Older, Low-Weight ACS Patients

THALES: Ticagrelor Plus Aspirin Cuts Repeat Events After Stroke, TIA

TCTMD’s Top 10 Most Popular Stories for June 2020

TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

TICONC: Ticagrelor May Cut Tumor-Induced Platelet Aggregation in Cancer Patients

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Stent Thrombosis May Be Presenting Feature of COVID-19

Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI

FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Clopidogrel vs Ticagrelor or Prasugrel in Patients 70 Years or Older With NTSE ACS: POPular Age

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content